Endogenous opioid peptides regulate gut sensitivity, motility, and secretion through mu, delta, and kappa receptors, making them therapeutic targets for irritable bowel syndrome.
3 receptor targetsMu, delta, and kappa opioid receptors each regulate different gut functions — targeting specific subtypes could treat specific IBS symptoms
What the researchers found
Endogenous opioid peptides regulate visceral pain sensitivity, gastrointestinal motility, and secretion through mu, delta, and kappa receptors in the brain, spinal cord, and enteric nervous system, with dysfunction potentially underlying IBS symptoms.
Why it matters
IBS affects up to 15% of the population with limited treatment options. Understanding the opioid peptide system in the gut could lead to targeted therapies that address specific symptoms — pain, diarrhea, or constipation — through different opioid receptor subtypes.
How the study worked
Review article synthesizing data on endogenous opioid peptide distribution, receptor pharmacology, and functional effects on gut sensory and motor function, with application to IBS pathophysiology and treatment.
What this study cannot tell us
Review based on knowledge through 1999. Some proposed mechanisms were still hypothetical. The complexity of IBS pathophysiology means opioid dysfunction is only part of the picture.
How to read the evidence
Moderate evidence from a comprehensive review integrating pharmacological, physiological, and clinical data on opioid peptide gut function.
When this study was published
Published in 1999. Peripherally-restricted opioid drugs for IBS (like eluxadoline) have since been developed, validating the therapeutic concept described here.
The bigger picture
The gut has its own extensive opioid system, separate from the brain's pain circuitry. Targeting gut-specific opioid receptors could treat IBS symptoms without the central side effects (sedation, addiction) of traditional opioid drugs.
Questions still open
- Can peripherally-restricted opioid drugs treat IBS without CNS side effects?
- Which opioid receptor subtype is most relevant for IBS pain versus motility symptoms?
- Is opioid peptide production altered in IBS patients?
Common questions
Does IBS involve opioid peptide problems?
Are opioid drugs used for IBS?
Read the original research
Role of opioid ligands in the irritable bowel syndrome.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 13 Suppl A, 71A-75A
Citation
Corazziari, E. (1999). Role of opioid ligands in the irritable bowel syndrome.. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 13 Suppl A, 71A-75A.